EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting DNA methyltransferases for cancer therapy

Kaiyue Wang, Zhangxu He, Gang Jin, Sasa Jin, Yuanbing Du, Shuo Yuan, Jingyu Zhang

Bioorganic Chemistry · 2024-10 · 151 · 107652

DOI: 10.1016/j.bioorg.2024.107652 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioorganic Chemistry, 2024-10. Verfasst von Kaiyue Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy College, Henan University of Chinese Medicine, 450046 Zhengzhou, PR China. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Enzyme Inhibitors. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 104 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA methyltransferases (DNMTs) play a crucial role in genomic DNA methylation. In mammals, DNMTs regulate the dynamic patterns of DNA methylation in embryonic and adult cells. Abnormal functions of DNMTs are often indicative of cancers, including overall hypomethylation and partial hypermethylation of tumor suppressor genes (TSG), which accelerate the malignancy of tumors, worsen the condition of patients, and significantly exacerbate the difficulty of cancer treatment. Currently, nucleoside DNMT inhibitors such as Azacytidine and Decitabine have been approved by the FDA and EMA for the treatment of acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), and myelodysplastic syndrome (MDS). Therefore, targeting DNMTs is a very promising anti-tumor strategy. This review mainly summarizes the therapeutic effects of DNMT inhibitors on cancers. It aims to provide more possibilities for the treatment of cancers by discovering more DNMT inhibitors with high activity, high selectivity, and good drug-like properties in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsEnzyme InhibitorsHumansAnimalsDNA (Cytosine-5-)-MethyltransferasesDNA Modification MethylasesDNA MethylationMolecular Structure

Stichwörter der Autor:innen

CancersDNA methylationDNMTsInhibitors

Substanzen

Antineoplastic AgentsEnzyme InhibitorsDNA (Cytosine-5-)-MethyltransferasesDNA Modification Methylases

Autor:innen und Institutionen

  • Pharmacy College, Henan University of Chinese Medicine, 450046 Zhengzhou, PR China.
  • Pharmacy College, Henan University of Chinese Medicine, 450046 Zhengzhou, PR China. Electronic address: hezhangxu123@163.com.
  • Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou 450018, PR China. Electronic address: zzuyuanshuo@163.com.
  • Pharmacy College, Henan University of Chinese Medicine, 450046 Zhengzhou, PR China. Electronic address: jyzhang2004@126.com.

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Wang, K., He, Z., Jin, G., Jin, S., Du, Y., Yuan, S., & Zhang, J. (2024). Targeting DNA methyltransferases for cancer therapy. Bioorganic Chemistry, 151, 107652. https://doi.org/10.1016/j.bioorg.2024.107652

Vancouver

Wang K, He Z, Jin G, Jin S, Du Y, Yuan S, et al. Targeting DNA methyltransferases for cancer therapy. Bioorganic Chemistry. 2024;151:107652. doi:10.1016/j.bioorg.2024.107652

BibTeX
@article{Wang2024,
  author = {Wang, Kaiyue and He, Zhangxu and Jin, Gang and Jin, Sasa and Du, Yuanbing and Yuan, Shuo and Zhang, Jingyu},
  title = {Targeting DNA methyltransferases for cancer therapy},
  journal = {Bioorganic Chemistry},
  year = {2024},
  volume = {151},
  pages = {107652},
  doi = {10.1016/j.bioorg.2024.107652}
}
Kostenlos starten →